A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
Ricardo Hitt(Hospital Universitario Severo Ochoa), Javier García(Hospital General Yagüe), D. Isla-Casado, M. Pastor-Borgoñón(Hospital Universitario Miguel Servet), Antonio Irigoyen López(Universidad de Murcia), Marta Guix(Hospital Del Mar), Javier Martínez‐Trufero(Hospital Universitario Miguel Servet), Juan Jesús Cruz(Universidad de Salamanca), Carmen Ruiz de Almodóvar(University of Bonn), P. Pastor-Gaitán, Enrique Santiago(Universidad de Oviedo), J.A. Brandariz Castelo(Hospital Universitario 12 De Octubre), E. Estefanía, Yolanda Escobar(Hospital Universitario Virgen de las Nieves), Jose Ramón Mel-Lorenzo, Carlos Jara-Sánchez, Javier Sastre(Hospital Clínico San Carlos), Carlos García Girón(Hospital General Yagüe), J. Satrustegui-Galdona, Antonio López–Pousa(Hospital de Sant Pau), E. Verger(Hospital Clínic de Barcelona), José M. Millán(Centre for Biomedical Network Research on Rare Diseases), Alfonso Berrocal, Juan J. Grau(Hospital Clínic de Barcelona), María Cruz Moreno(Hospital Universitario Miguel Servet), H. Cortés-Funes(Centre Hospitalier René-Dubos), M.R. Leitão-Silva, A. Rodríguez-Jaráiz, Emilio Fonseca‐Sánchez
Cited by 351
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
|New England Journal of Medicine|2008|3.7k
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection
|Nature Genetics|2018|1.7k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k